Human Kidney Cancer Tissue Lysates

Pricing
Normal Lysates:  $125/100 ug
Tumor Lysates:   $175/100 ug
Nor./Tum. set: $270.00 (10% off)
Discounts
2-8    Vials  10%
9-20  Vials  15%
>20   Vials  20%

Call, Fax, or Email Your Order!

Introduction:

Histologic types of kidney cancer include the following:
Approximately 85% of renal cell cancers are adenocarcinomas, and most of those are of proximal tubular origin. Most of the remainder are transitional cell carcinomas of the renal pelvis (refer to the PDQ summary on Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment for more information). Adenocarcinomas may be separated into clear cell and granular cell carcinomas; however, the 2 cell types may occur together in some tumors. Some investigators have found that granular cell tumors have a worse prognosis, but this finding is not universal. The distinction between well-differentiated renal adenocarcinomas and renal adenomas can be difficult. The diagnosis is usually made arbitrarily on the basis of size of the mass, but size alone should not influence the treatment approach, since metastases can occur with lesions as small as 0.5 centimeters.

Human Kidney Cancer Lysates

Catalog Number

Diagnosis

Grade

Stage

TNM

Sex

Age

T11-001

Papillary renal cell carcinoma

1

n/a

n/a

M

56

T11-002

Renal clear cell carcinoma

1

n/a

n/a

F

40

T11-003

Papillary renal cell carcinoma

1

n/a

n/a

M

65

T11-004

Renal clear cell carcinoma

1

II

T2N0M0

F

48

T11-005

Renal clear cell carcinoma

1

II

T3N0M0

F

62

T11-006

Renal clear cell carcinoma

2

II

n/a

F

69

T11-007

Renal clear cell carcinoma

3

III

T2N0Mx

M

57

T11-009

Renal clear cell carcinoma

3

III

T3bN0Mx

F

44

T11-013

Renal clear cell carcinoma

n/a

n/a

n/a

F

42

T11-014

Renal cysts

n/a

n/a

n/a

M

82

T11-015

Renal clear cell carcinoma

n/a

n/a

n/a

F

39

T11-016

Renal clear cell carcinoma

n/a

n/a

n/a

F

41

T11-017

Renal clear cell carcinoma

n/a

n/a

n/a

M

4

T11-018

Renal clear cell carcinoma

n/a

II

n/a

M

60

T11-019

Renal clear cell carcinoma

n/a

II

n/a

M

29

T11-020

Renal clear cell carcinoma

n/a

II

n/a

M

64

T11-021

Renal clear cell carcinoma

3

II

n/a

M

45

T11-022

Transitional cell carcinoma

2

II

T2N0M0

M

42

T11-023

Adenocarcinoma

3

II

T2N0M0

M

37

T11-024

Renal clear cell carcinoma

1

n/a

n/a

F

37

T11-025

Clear cell carcinoma, moderately differentiated.

2

n/a

n/a

M

69

T11-026

Clear cell carcinoma, moderately differentiated.

2

n/a

n/a

F

60

T11-027

Clear cell carcinoma, moderately differentiated.

2

II

T2N0M0

F

60

T11-028

Clear cell carcinoma, moderately differentiated.

2

n/a

n/a

M

70

T11-029

Clear cell carcinoma, moderately differentiated.

2

n/a

n/a

M

53

T11-030

Clear cell carcinoma, moderately differentiated.

2

n/a

n/a

F

59

T11-031

Clear cell carcinoma, moderately differentiated.

2

n/a

n/a

M

71

T11-032

Clear cell carcinoma, moderately differentiated.

2

n/a

n/a

M

68

T11-033

Clear cell carcinoma, moderately differentiated.

2

n/a

n/a

M

57

T11-034

Clear cell carcinoma, moderately differentiated.

2

n/a

n/a

M

54

T11-035

Clear cell carcinoma, moderately differentiated.

2

n/a

n/a

M

39

T11-036

Clear cell carcinoma, well differentiated.

1

III

T2N0M0

M

49

T11-037

Clear cell carcinoma, moderately differentiated.

2

I

T1bN0M0

M

60

T11-038

Clear cell carcinoma, moderately differentiated.

2

I

T1N0M0

F

48

T11-039

Clear cell carcinoma, moderately differentiated.

2

n/a

n/a

F

60

T11-040

Renal cell carcinoma, poorly differentiated.

3

II

T2N0M0

F

52

T11-041

Renal cell carcinoma, moderately differentiated.

2

n/a

n/a

M

88

T11-042

Transitional cell carcinoma.

2

n/a

n/a

M

48

T11-043

Transitional cell carcinoma, moderately differentiated.

2

n/a

n/a

F

64

T11-044

Transitional cell carcinoma, poorly differentiated.

3

n/a

n/a

M

58

T11-045

Renal granular cell carcinoma, moderately differentiated.

2

n/a

n/a

M

41

T11-046

Papillary renal cell carcinoma, moderately differentiated.

2

n/a

n/a

F

31

T11-047

Adenocarcinoma, poorly differentiated.

3

n/a

T4N1M0

F

71

T11-048

Sarcoma, moderately differentiated.

2

II

T2N0M0

F

30

 

References:

Mostofi FK, Davis CJ, Sesterhenn IA: Pathology of tumors of the urinary tract. In: Skinner DG, Lieskovsky G, eds.: Diagnosis and Management of Genitourinary Cancer. Philadelphia, Pa: WB Saunders, 1988., pp 83-117.

Wilson TG, Pritchett TR, Lieskovsky G, et al.: Primary adenocarcinoma of bladder. Urology 38 (3): 223-6, 1991.

LiVolsi VA: Pathology of thyroid disease. In: Falk SA: Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine, and Radiotherapy. Philadelphia, PA: Lippincott-Raven, 1997., pp 127-175.